Login or Sign Up
15:52 Jan 21
Corona Remedies Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Corona Remedies Ltd. Financials
Corona Remedies Ltd.
Industry Pharmaceuticals
15:52 Jan 21
Quality
0/100
Not Eligible
Valuation
5/100
Expensive Valuation
Technical
0/100
No Score Avaliable
Strength
6
Weakness
4
Opportunity
0
Threats
0
24.64 %
ROE %
16.07 %
ROA %
0.00
EPS
99.14
BVPS
12.49 %
Net Profit Margin
| Mar 2023 | Mar 2024 | Mar 2025 | ||
|---|---|---|---|---|
| Net Sales | 884.05 | 1014.47 | 1196.42 | |
| Operating Expenses + | 756.07 | 859.74 | 956.44 | |
| Raw Material | 225.47 | 227.6 | 260.26 | |
| Increase Decrease in Cost | -14.51 | -0.78 | -23.74 | |
| Other Manufacturing Expense | 0 | 0 | 0 | |
| Employee Cost | 254.77 | 295.37 | 346.14 | |
| Miscellaneous Expenses | 543.08 | 587.29 | 689.72 | |
| Operating Profit | 127.98 | 154.73 | 239.98 | |
| Other Income | 7.05 | 6.46 | 5.94 | |
| Depreciation | 20.1 | 28.28 | 37.16 | |
| Interest | 4.27 | 14.44 | 10.6 | |
| Profit before tax and exceptio.. | 110.66 | 118.48 | 198.15 | |
| Exceptional Items | 0 | 0 | 0 | |
| PBT | 110.66 | 118.48 | 198.15 | |
| Provision for Taxation | 25.96 | 27.98 | 49.1 | |
| Net Profit | 84.7 | 90.5 | 149.05 | |
| NET Profit after MI | 84.93 | 90.5 | 149.43 | |
| EPS | 14.57 | 14.8 | 24.43 | |
| Operating Profit Margin (%) | 14.48 | 15.25 | 20.06 | |
| Net Profit Margin (%) | 9.61 | 8.92 | 12.49 |
Corona Remedies Ltd. Shareholding
Promoter
FII
Public
All Data in Percentage (%)
| Dec 2025 | |
|---|---|
| Promoter | 69.00 |
| FII | 1.80 |
| Public | 6.80 |
| Others | 22.40 |
| Shareholder | Shares | Holding % |
|---|
Download Our App On:
Back
OTP sent to your mobile number. Please enter it below to verify.
Verify Email OTP
OTP sent to
Dear User, please
complete your profile!
Email ID Already Exists
Location Saved
Successfully
Email Id Verified
Successfully